Basic information |
Metabolite name | Adenine |
HMDB0000034 | |
C00147 | |
190 | |
Synonyms | NA |
No. of studies | 29 |
Relationship between Adenine and depression (count: 29) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Up |
Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Up |
Study M181 | Type3 | venlafaxine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
Study M207 | Type1 | depressed group vs. control group | Faece | Kunming mouse | Down |
Study M472 | Type3 | (2S,6S)-HNK group vs. control group | PC12 cell | Rat | Up |
Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Down |
Study M613 | Type1 | CSDS susceptible group vs. control group | Nucleus accumbens | C57BL/6 J mouse | Up |
Study M616 | Type1 | CUMS group vs. control group | Olfactory bulb | Sprague-Dawley rat | Down |
Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort | Plasma | Human | Up |
Study M663 | Type3 | diterpene ginkgolides group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
Study M676 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Down |
Study M676 | Type2 | CVS + antibiotic group vs. CVS group | Hippocampus | Wistar rat | Up |
Study M755 | Type1 | high-dose D-ribose group vs. control group | Hippocampus | C57BL/6J mouse | Down |
Study M769 | Type1 | CSDS group vs. control group | Amygdala | Sprague-Dawley rat | Up |
Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Up |
Study M787 | Type1 | CRS group vs. control group | Colon | Wistar rat | Down |
Study M826 | Type1 | CVS group vs. control group | Ileum | Wistar rat | Up |
Study M828 | Type1 | ultrasonic radiation group vs. control group | Frontal cortex | Wistar rat | Down |
Study M828 | Type2 | ultrasonic radiation + intraperitoneally clomipramine group vs. ultrasonic radiation group | Hippocampus | Wistar rat | Up |
Study M844 | Type1 | CORT group vs. control group | PC12 cell | Rat | Up |
Study M846 | Type1 | postpartum depression model group vs. control group | Hippocampus | BALB/c mouse | Down |
Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Faece | BALB/c mouse | Down |
Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
Study M847 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
Study M847 | Type2 | CUMS + Bupleuri Radix group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
Study M870 | Type2 | CRS + sertraline group vs. CRS group | Brain | C57BL/6 mouse | Up |
Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
Study M927 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
Study M927 | Type2 | CUMS + Zhi-zi-chi decoction group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Up |
Study M940 | Type2 | CUMS + Chaihu-Baishao herb pair group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Down |
Study M957 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Down |
Study M957 | Type1 | CSDS group vs. control group | Serum | C57BL/6 J mouse | Down |